Mentions
Extended reach
Total likes
Video views
AI synopsis
The collection reveals a high level of interest and engagement, with mentions of specific studies like Metformin as an inhibitor and discussions on the pathway's role in drug resistance, demonstrating the community's focus on therapeutic advances. The tone varies from informative summaries to speculative optimism about future applications, underpinning the perceived high impact of these developments.
Most discussions acknowledge the importance of Wnt signaling in cancer, with some referencing therapeutic potential and recent research advances, indicating general consensus on its significance.
Posts demonstrate high interest, highlighting novel inhibitors like Metformin and potential drug development avenues, reflecting curiosity and engagement with cutting-edge research.
Several posts delve into complex topics such as cancer stem cells, drug resistance mechanisms, and specific molecular interactions, suggesting deep engagement.
The discussions emphasize the promising outlook of targeting the Wnt pathway for treatments and the significance of recent findings for cancer therapy, indicating high perceived impact.
Dr. David Tuveson, a member of the @SU2C Scientific Advisory Committee, published a summary of a Banbury Center meeting in Science Signaling, discussing the future of the role of the Wnt signaling pathway in cancer research https://t.co/KaEdI2X2aj
Metformin: A New Inhibitor of the Wnt Signaling Pathway in Cancer - PubMed https://t.co/grVb0fuCuV
RT @SU2Cscience: Dr. David Tuveson, a member of the @SU2C Scientific Advisory Committee, published a summary of a Banbury Center meeting in…
RT @SU2Cscience: Dr. David Tuveson, a member of the @SU2C Scientific Advisory Committee, published a summary of a Banbury Center meeting in…
RT @mlazqui: Metformin: A New Inhibitor of the Wnt Signaling Pathway in Cancer - PubMed https://t.co/grVb0fuCuV
RT @SU2Cscience: Dr. David Tuveson, a member of the @SU2C Scientific Advisory Committee, published a summary of a Banbury Center meeting in…
We deliver knowledge on health, nutrition, and lifestyle choices based on scientific studies. Certain foods have been associated with an increased risk of cancer development, particularly ultra-processed foods and…
RT @mlazqui: Metformin: A New Inhibitor of the Wnt Signaling Pathway in Cancer - PubMed https://t.co/grVb0fuCuV
Metformin: A New Inhibitor of the Wnt Signaling Pathway in Cancer - PubMed https://t.co/grVb0fuCuV
The role of the Wnt signaling pathway in cancer stem cells: prospects for drug development https://t.co/EDdVgoCGoO
RT @SU2Cscience: Dr. David Tuveson, a member of the @SU2C Scientific Advisory Committee, published a summary of a Banbury Center meeting in…
RT @SU2Cscience: Dr. David Tuveson, a member of the @SU2C Scientific Advisory Committee, published a summary of a Banbury Center meeting in…
RT @SU2Cscience: Dr. David Tuveson, a member of the @SU2C Scientific Advisory Committee, published a summary of a Banbury Center meeting in…
RT @SU2Cscience: Dr. David Tuveson, a member of the @SU2C Scientific Advisory Committee, published a summary of a Banbury Center meeting in…
RT @SU2Cscience: Dr. David Tuveson, a member of the @SU2C Scientific Advisory Committee, published a summary of a Banbury Center meeting in…
Dr. David Tuveson, a member of the @SU2C Scientific Advisory Committee, published a summary of a Banbury Center meeting in Science Signaling, discussing the future of the role of the Wnt signaling pathway in cancer research https://t.co/KaEdI2X2aj
BM-MSCs enhance the chemoresistance of ovarian cancer by releasing miR-1180.The released miR-1180 activates the wnt signaling pathway in cancer cells by targeting SFRP1.The enhanced wnt signaling upregulates the glycolytic level, which reinforces the… https://t.co/KgLL5MohiR https://t.co/Yc97lszRN3
SC
ML
LC
LF
C
O
DL
SR
KP
JZ